Onderneming Curis, Inc. Nasdaq
Aandelen
US2312691015
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Discovery and Development of Innovative Drug
100,0
%
| 10 | 100,0 % | 10 | 100,0 % | -1,37% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 10 | 100,0 % | -1,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Dentzer
CEO | Chief Executive Officer | 57 | 29-03-16 |
Diantha Duvall
DFI | Director of Finance/CFO | 52 | 26-07-22 |
Chief Tech/Sci/R&D Officer | - | 03-01-22 | |
Chief Tech/Sci/R&D Officer | - | 13-08-19 | |
Robert Martell
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-09-11 |
Mark W. Noel
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-03-01 |
Rachel Blasbalg
HRO | Human Resources Officer | - | 01-01-04 |
Dora Ferrari
PRN | Corporate Officer/Principal | - | 03-01-21 |
Nancy Soohoo
LAW | General Counsel | - | 01-01-03 |
Jonathan Zung
PRN | Corporate Officer/Principal | 59 | 01-05-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kenneth Kaitin
BRD | Director/Board Member | 71 | 01-11-03 |
Martyn Greenacre
CHM | Chairman | 82 | 14-02-00 |
James Dentzer
CEO | Chief Executive Officer | 57 | 29-03-16 |
Marc Rubin
BRD | Director/Board Member | 69 | 03-06-10 |
Robert Martell
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-09-11 |
Anne Borgman
BRD | Director/Board Member | 56 | 01-10-22 |
John Hohneker
BRD | Director/Board Member | 64 | 02-12-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 894 085 | 5 883 204 ( 99,82 %) | 0 | 99,82 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,37% | 48,16 mld. | |
-1,01% | 41,73 mld. | |
+42,83% | 41,03 mld. | |
-5,31% | 28,77 mld. | |
+9,34% | 25,59 mld. | |
-21,69% | 18,96 mld. | |
+6,23% | 12,92 mld. | |
+26,99% | 12,03 mld. | |
-3,38% | 11,77 mld. |